CD52-directed Cytolytic Antibody [EPC] class drugs

2 results

  • lemtrada - alemtuzumab injection, solution, concentrate

    (Alemtuzumab)
    Genzyme Corporation
    Lemtrada treats relapsing forms of multiple sclerosis—including relapsing-remitting and active secondary progressive disease—in adults. Due to its safety profile, it is generally reserved for patients who have not responded adequately to two or more other MS medications. Not recommended for clinically isolated syndrome.
    Medication Details
    Drug Interactions